← Open Payments lookup

ERIN BROSAMER: Open Payments

NPI 1710534359 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,666 in 248 payments from 21 companies in 2025. Trend: 2023 $4,422 · 2024 $5,628 · 2025 $5,666

Food & beverage: $5,546Education: $120
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$716
Janssen Pharmaceuticals, Inc19$674
Otsuka America Pharmaceutical, Inc.25$564
Teva Pharmaceuticals USA, Inc.22$539
Vanda Pharmaceuticals Inc.21$467
ABBVIE INC.19$449
Alkermes, Inc.20$447
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$446
Lundbeck LLC15$301
Takeda Pharmaceuticals U.S.A., Inc.17$209

Products named: INGREZZA, REXULTI, SPRAVATO, FANAPT, VRAYLAR, ARISTADA, CAPLYTA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.